SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-009470
Filing Date
2018-04-27
Accepted
2018-04-27 09:15:17
Documents
3
Period of Report
2018-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20180427.htm 8-K 23932
2 EX-99.1 sbph-ex991_7.htm EX-99.1 122479
3 GRAPHIC g2018042622420703624318.jpg GRAPHIC 4287
  Complete submission text file 0001564590-18-009470.txt   153580
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 18781257
SIC: 2834 Pharmaceutical Preparations